Consistent with transcriptional changes, there was a significant decrease in Bcl2 and Bcl-XL protein levels in fibroblasts by the ECM compared to media, and this decrease was attenuated with CML modification of the ECM (Figure 5B–D). The gene discussed is BCL2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.